#PANALYTICAL SOFTWARE ACTIVATION PLUS#

The Plus option adds phase fits (Rietveld, Pawley, LeBail and more), standardless quantifications with crystal structures and scripting to the basic HighScore package. The CSD is the most recent reference database added to HighScore. The (semi-) automatic handling of many datasets by configurable batches and similarity analysis are distinguishing features.

#PANALYTICAL SOFTWARE ACTIVATION SOFTWARE#

The HighScore software offers X-ray diffraction data treatments, phase identifications, reporting and profile fits. Containing over 875,000 entries from X-ray and neutron diffraction analyses, this unique database of accurate 3D structures has become an essential resource to scientists around the world. Established in 1965, the CSD is the worldвЂ™s repository for small-molecule organic and metal-organic crystal structures. The Cambridge Structural Database (CSD) is a highly curated and comprehensive resourceВ that is essential toВ scientists around the world. This new feature is the result of the close collaboration between the renowned Cambridge Crystallographic Data Centre and PANalytical, a leading supplier of analytical X-ray instrumentation and software. This aligns closely with the Spectris strategy of a shift in emphasis towards the provision of complete solutions to our customers, allowing us to better deliver this to our Malvern and PANalytical customers.PANalytical and the Cambridge Crystallographic Data Centre (CCDC) have agreed that users of the Cambridge Structural Database (CSD) can now utilize this database in PANalyticalвЂ™s HighScore software suite for the analysis of powder diffractograms without additional costs. Joining the two companies will enable us to leverage new resources to further grow our service offering and add even more value to our clients and customers. Peter van Velzen, President of PANalytical, and Paul Walker, President of Malvern, will be retiring, as previously planned.Д®oghan OвЂ™Lionaird, Business Group Director responsible for the Materials Analysis segment, says: вЂњThis is an exciting time for Malvern and PANalytical. Previously, Paolo spent 23 years with Honeywell Corporation, most recently holding the position of President of the Aerospace business in EMEA. He was, most recently, Operating Partner at CSTS Healthcare, Ltd., a privately held software business developing artificial intelligence solutions for personalised therapies in oncology. Paolo brings with him a wealth of experience in global high-technology business management. This aligns with the Spectris strategy of focusing on the supply of innovative customer solutions, involving the provision of services, software and related activities alongside the supply of equipment.ДЄ new President of the merged operating company, Paolo Carmassi, has been appointed, effective immediately. The merger is being undertaken as there are clear benefits through this more collaborative relationship, leveraging the very strong brands and highly-skilled employees of the two companies, in order to deliver a more complete range of products, solutions and services to a broader set of markets and customers. The combined entity is a strong player in the materials characterisation market and will be able to leverage the strengths of the individual companies in their end markets. The companies are both world leading suppliers of analytical instrumentation, PANalytical for X-ray instrumentation and software for the purpose of materials analysis and Malvern Instruments for materials and biophysical characterisation technology. Both Malvern and PANalytical are operating companies within the Materials Analysis segment of Spectris. Spectris plc announces that effective 1 January 2017, Malvern Instruments and PANalytical will be merging their activities.

Panalytical software activation